Dr Reddy's Labs drops over 5 pc on BSE
Dr Reddy's Laboratories today fell amid media reports that a US drug maker has sued the company for patent infringement.
By PTI | Updated:
MUMBAI: Dr Reddy's Laboratories today fell by a little over 5 per cent on Bombay Stock Exchange (BSE) amid media reports that a US drug maker has sued the company for patent infringement.
The pharma major closed 5.07 per cent down at Rs 1,599.20 on the BSE. During intra-day trade, it had shed 6.26 per cent to Rs 1,579 a piece.
Besides, the scrip closed 4.64 per cent lower at Rs 1,605 on the National Stock Exchange.
According to media reports, New Jersey-based Medicines Co has filed a suit in a US court alleging that Dr Reddy's is infringing its patent to make the generic version of bivalirudin, a drug used as an anticoagulant in angioplasty procedures.
Meanwhile, the BSE benchmark Sensex today closed 65.33 points, or 0.35 per cent down at 18,469.36.
The pharma major closed 5.07 per cent down at Rs 1,599.20 on the BSE. During intra-day trade, it had shed 6.26 per cent to Rs 1,579 a piece.
Besides, the scrip closed 4.64 per cent lower at Rs 1,605 on the National Stock Exchange.
According to media reports, New Jersey-based Medicines Co has filed a suit in a US court alleging that Dr Reddy's is infringing its patent to make the generic version of bivalirudin, a drug used as an anticoagulant in angioplasty procedures.
Meanwhile, the BSE benchmark Sensex today closed 65.33 points, or 0.35 per cent down at 18,469.36.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
